NPI: 1912455577 · NORTH CHESTERFIELD, VA 23234 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/13/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/13/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,287 | $24K |
| 2019 | 9,666 | $178K |
| 2020 | 14,616 | $192K |
| 2021 | 10,901 | $167K |
| 2022 | 8,301 | $238K |
| 2023 | 8,875 | $213K |
| 2024 | 4,495 | $182K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,001 | 1,308 | $1.01M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 772 | 62 | $101K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,546 | 913 | $38K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 366 | 165 | $23K |
| J1756 | Injection, iron sucrose, 1 mg | 4,811 | 822 | $11K |
| A4657 | Syringe, with or without needle, each | 3,440 | 834 | $6K |
| J1644 | Injection, heparin sodium, per 1000 units | 261 | 25 | $241.73 |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,418 | 478 | $234.96 |
| 83970 | 341 | 194 | $64.40 | |
| 82728 | 151 | 78 | $16.00 | |
| 83550 | 143 | 76 | $10.75 | |
| 83540 | 143 | 76 | $7.95 | |
| 85041 | 348 | 197 | $5.31 | |
| 85048 | 349 | 197 | $4.51 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 33 | 12 | $1.64 |
| G0008 | Administration of influenza virus vaccine | 18 | 12 | $0.00 |